bmiMD

Product Details

bmiMD describes its program as a fully online service that connects eligible customers with licensed medical professionals and independent pharmacies. Treatment availability and prescribing decisions depend on the provider’s clinical assessment.

What Is bmiMD GLP-1 Weight Loss Program?

bmiMD is an online prescription weight-management platform offering compounded GLP-1 and GLP-1/GIP treatment options. Its primary options include compounded semaglutide and compounded tirzepatide, both provided as at-home injectable treatments for eligible customers.

The program combines an online health assessment and provider consultation with prescription fulfillment through an independent pharmacy when treatment is appropriate. Ongoing provider messaging, medication-related support and convenient refills are also included as part of the program.

Who May Consider bmiMD GLP-1 Weight Loss Program?

The program may be considered by adults seeking prescription-supported weight-management care and who are appropriate candidates following a medical evaluation. bmiMD provides an online intake process followed by a consultation with a licensed medical professional.

People interested in prescription weight-management options can use the service to discuss their goals, medical history and treatment choices with a qualified provider. Anyone experiencing unexplained weight changes or ongoing health symptoms should seek appropriate professional medical evaluation.

How May bmiMD GLP-1 Treatment Support General Wellness?

Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP pathways. bmiMD describes these treatments in relation to appetite regulation and weight-management support.

The program also provides clinical communication, prescription management and refill support alongside the selected medication. Treatment plans can vary according to the prescribing provider’s clinical judgement, individual circumstances and treatment response.

For eligible individuals, this structure provides a convenient way to access prescription weight-management care online while maintaining communication with a medical provider.

Supplement Facts

The public product pages do not disclose a single standardized Supplement Facts-style ingredient table with fixed amounts per serving. Medication concentration and dosing can vary according to the prescription issued by the licensed healthcare provider.

Compounded Semaglutide

• Active medication: Semaglutide
• Medication class: GLP-1 receptor agonist
• Form: Injectable
• Amount per dose: Provider-prescribed; not publicly disclosed as one fixed amount

Compounded Tirzepatide

• Active medication: Tirzepatide
• Medication class: GLP-1/GIP receptor agonist
• Form: Injectable
• Amount per dose: Provider-prescribed; not publicly disclosed as one fixed amount

Active Ingredients

The two primary treatment options contain prescription medications selected through provider evaluation and are intended for medically supervised weight-management care.

Semaglutide

Semaglutide is a GLP-1 receptor agonist that acts on pathways involved in appetite regulation. bmiMD provides compounded semaglutide as an at-home injectable option for eligible customers.

Tirzepatide

Tirzepatide acts on both GLP-1 and GIP pathways involved in appetite and metabolic regulation. bmiMD provides compounded tirzepatide as an injectable treatment option following provider evaluation.

Potential Benefits

• May support a structured approach to weight management through prescription care.
• Provides access to semaglutide, a GLP-1 treatment option, when clinically appropriate.
• Provides access to tirzepatide, a GLP-1/GIP treatment option, when clinically appropriate.
• Includes online provider evaluation and ongoing medication-related communication.
• Offers flexible plan durations with delivery and refill support.

Important Limitations

• Treatment eligibility is determined by a licensed healthcare provider.
• Individual treatment plans and dosing may vary according to clinical judgement.
• Medication formulation details can vary between dispensing pharmacies.
• Prescription medication should be used according to the instructions provided by the healthcare professional.

How to Use?

bmiMD’s GLP-1 treatments come in an injectable form for at-home administration.

• Use the medication only according to the dosage and administration instructions provided by the prescribing healthcare professional.
• The appropriate dose is determined as part of the individual’s prescription and treatment plan.
• Follow the dispensing pharmacy’s instructions for injection technique and administration.
• Follow the pharmacy’s storage instructions supplied with the medication.
• Do not change the prescribed dose or administration schedule without discussing it with the prescribing provider.

A fixed treatment duration or universal maximum dose is not publicly specified because treatment plans are individualized.

Warnings and Precautions

• Prescription GLP-1 medications require evaluation by a licensed healthcare provider before use.
• Discuss pregnancy, breastfeeding or plans to become pregnant with the prescribing provider before treatment.
• Tell the provider about current prescription medications, non-prescription medicines and supplements.
• Provide a complete medical history, including relevant gastrointestinal, pancreatic, kidney or other medical conditions.
• People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should discuss this with their healthcare provider before using GLP-1 treatment.
• People using insulin or insulin-secretagogue medications should discuss treatment with their provider because medication adjustments may be appropriate.
• Seek medical attention for serious or persistent reactions, including severe abdominal pain, significant allergic symptoms or other concerning changes.
• Keep injectable medication stored according to the dispensing pharmacy’s instructions and away from children.

Possible Side Effects and Interactions

Common effects associated with GLP-1 treatments can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite and indigestion. Some people may also experience injection-site reactions or other gastrointestinal effects. GLP-1 medications can interact with certain medicines, including insulin and insulin secretagogues, and may affect absorption of some oral medications. Consult a pharmacist or healthcare professional about your medication list.

Manufacturing and Quality Information

bmiMD states that prescriptions may be fulfilled through licensed U.S.-based compounding pharmacies within its network. Its website also describes pharmacy quality-control testing through FDA- and DEA-registered laboratories.

The quality-control information presented by bmiMD includes:

• Potency testing
• Sterility testing
• pH testing
• Endotoxin testing

The site states that potency testing is performed every three to six months and that sterile products undergo testing consistent with USP 797 requirements. It also describes endotoxin testing against USP 85 limits.

• Manufacturer: Dispensing pharmacy varies
• Manufacturing location: Licensed U.S. compounding pharmacy network
• Third-party testing: Testing through FDA- and DEA-registered laboratories is described

Pros

• Online provider consultation is included.
• At-home injectable treatment provides a convenient administration format.
• Semaglutide and tirzepatide options are available.
• Multiple plan durations provide flexible payment choices.
• Subscription orders include free shipping and ongoing clinician access.

Cons

• Prescription eligibility must be established by a licensed provider.
• Treatment and dosing can vary according to individual clinical assessment.
• Inactive ingredients and exact formulation details are not publicly disclosed.

Pricing Options

bmiMD offers compounded semaglutide and tirzepatide options through an online weight-management program, with treatment plans selected based on individual eligibility and weight-loss goals. 

bmiMD currently offers several plan durations with lower monthly rates for longer commitments and free subscription shipping.

Compounded Semaglutide

• 12-month plan: $119/month – $1,428 total, billed annually.
• 6-month plan: $129/month – $774 total, billed every six months.
• 3-month plan: $149/month – $447 total, billed every three months.
• Monthly plan: $159/month – $159 total, billed monthly.

Shipping is free on subscription orders, with recurring billing based on the selected plan. The consultation or program eligibility fee is refundable if the patient is determined to be ineligible for the program.

Compounded Tirzepatide

• 12-month plan: $179/month – $2,148 total, billed annually.
• 6-month plan: $189/month – $1,134 total, billed every six months.
• 3-month plan: $229/month – $687 total, billed every three months.
• Monthly plan: $249/month – $249 total, billed monthly.

Shipping is free on subscription orders. The program uses recurring billing based on the selected plan, while the consultation or program eligibility fee is refundable when a patient is determined to be ineligible for the program.

Pricing and availability were checked on August 28, 2026 and may change on the official website.

Pharmacist Note

Prescription GLP-1 treatment should be used exactly as directed by the prescribing healthcare professional. Before starting treatment, review your medication list, existing health conditions and any overlapping therapies with your provider or pharmacist to support appropriate use.

Frequently Asked Questions

1. What type of product is bmiMD?

bmiMD is an online prescription weight-management program offering compounded semaglutide and compounded tirzepatide injection options.

2. How should bmiMD GLP-1 medication be taken?

The medication is administered by injection according to the individualized dosage and administration instructions provided by the prescribing healthcare professional.

3. How long does one plan last?

Available plans provide approximately one, three, six or twelve months of treatment, depending on the selected billing option.

4. Can it be taken with prescription medication?

Medication compatibility varies by individual. Discuss all current prescriptions, non-prescription medicines and supplements with your healthcare provider.

5. Is it suitable during pregnancy or breastfeeding?

Pregnancy and breastfeeding require individualized medical guidance. Discuss pregnancy, breastfeeding or plans to conceive with your prescribing healthcare professional.

6. Where can bmiMD treatment be purchased?

bmiMD provides its program online, with eligible prescriptions fulfilled through independent licensed pharmacies within its pharmacy network.

Medical Disclaimer

“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before using a dietary supplement, particularly if you are pregnant, breastfeeding, taking medication or managing a medical condition.”

Sources and Product Review Information

• Official product information: bmiMD compounded semaglutide and compounded tirzepatide pages.
• Current pricing information: bmiMD product pages, checked August 28, 2026.
• Safety information: bmiMD Important Safety Information.
• Manufacturing and quality information: bmiMD website quality-control information.
• Ingredient and medication information: Product-specific information is based on the currently available bmiMD treatment pages and safety information.

Affiliate Disclosure: This page may contain affiliate links. If you make a purchase through one of these links, we may earn a commission at no additional cost to you. This does not influence the information presented above, which is based on publicly available product and label information.